What are the most common mistakes in IFU translation?

The most common mistakes are inconsistent terminology, missing regulatory review, failure to consider country-specific requirements, inadequate translator qualifications, and lack of version control. Each of these errors can lead to approval delays or even product recalls.

How can I ensure my IFU translations are MDR compliant?

Ensure translators are familiar with medical terminology, use a translation memory for consistent terminology, have qualified specialists perform a regulatory review, and document the entire translation process in accordance with ISO 13485.

Do I need a certified translator for instructions for use?

The MDR does not formally require certified translators, but translations must be accurate and comprehensible. In practice, it is advisable to use translators with proven medical device experience and to document the translation process as part of your QMS.

Best Practices

5 Common Mistakes in IFU Translation

And How to Avoid Them in Your Translation Process

8 min read

Why IFU Translations Are So Demanding

Translating Instructions for Use (IFUs) for medical devices is one of the most demanding disciplines in specialized translation. Unlike general marketing copy, this involves patient safety, regulatory compliance, and legal liability. A single translation error can have serious consequences — from delaying market approval to triggering a product recall.

Under the EU Medical Device Regulation (MDR 2017/745), manufacturers must ensure that all information supplied with the device is available in the official language of each Member State. That means up to 24 languages for the EU market alone. The pressure on quality and efficiency is immense. At the same time, documentation requirements for the translation process itself are increasing — Notified Bodies are increasingly reviewing evidence of language quality as part of conformity assessment.

Mistake 1: Inconsistent Terminology

The most common and most dangerous mistake is the inconsistent use of technical terms. When the same component is referred to differently in various sections of the IFU, it can cause confusion for the user and ultimately lead to misuse.

For example, if "Einführhilfe" is translated as "introducer" in one section and "insertion aid" in another, the user cannot be certain whether the same component is being referenced. In medical technology, such confusion can have fatal consequences.

The solution lies in systematic terminology management. Create a glossary for each product that is binding across all languages, and deploy a translation memory system that automatically suggests consistent terminology. Tools like manualworks help you manage terminology databases centrally and apply them across projects.

Mistake 2: Missing Regulatory Review

Many companies treat IFU translation as a purely linguistic process and overlook the regulatory dimension. However, a linguistically correct translation is not automatically a regulatory-compliant translation. Each target market has its own requirements for labeling, warnings, and symbol usage.

For instance, the MDR requires that warnings comply with ISO 15223-1 and IEC 62366-1. Some countries impose additional national requirements — such as symbol placement or the sequencing of safety information. A purely linguistic translation without regulatory validation is a risk you should not take.

Practical Tip

Integrate a regulatory review step into your translation workflow. A Regulatory Affairs Specialist should review every translated IFU before release — not for language quality, but for regulatory correctness. Document this review step as part of your quality management system.

Mistake 3: Ignoring Country-Specific Requirements

The EU MDR defines common minimum requirements, but country-specific particularities exist beyond these. In France, for example, strict requirements apply to the use of the French language (Loi Toubon). In Nordic countries, specific phrasings for safety notices are mandated. Some Member States also impose additional requirements for font size or contrast design on labels.

Failing to recognize and address these differences risks objections during the approval process or during market surveillance activities. Thorough country research at the outset of every translation project is essential.

Mistake 4: Using Unqualified Translators

Medical translation requires more than general language proficiency. Translators must be familiar with the relevant standards (ISO 13485, IEC 62366, ISO 14971), master medical terminology, and understand the regulatory landscape. General translation agencies without medical device specialization are often unsuitable for IFU translation.

When selecting translation service providers, verify their references in the medical device sector. Ask about experience with specific product categories and regulatory requirements. A translator experienced with orthopedic implants is not automatically qualified for in vitro diagnostics. The specialist expertise must match the product.

Mistake 5: No Version Control

Instructions for use are regularly updated throughout the product lifecycle — whether due to product changes, new regulatory requirements, or post-market surveillance findings. Without consistent version control, you quickly lose track of which language version is at which revision. The result: outdated translations reach the market, and your audit trail becomes incomplete.

This becomes particularly critical when safety-relevant changes — such as new contraindications or modified warnings — are not promptly incorporated into all language versions. In such cases, a potential compliance risk exists that will be immediately flagged during an audit.

manualworks solves this problem through integrated version management that automatically tracks every change to the source text across all target languages and alerts you to pending updates. This ensures all language versions are always up to date.

Conclusion

IFU translation is not a side process — it is a safety-critical component of your product documentation. Each of the five mistakes described can lead to significant consequences: from delayed market approvals to objections from Notified Bodies to product recalls. Invest in structured processes, qualified translators, and appropriate tools to avoid costly mistakes and accelerate your market approvals.